<bill session="115" type="s" number="2478" updated="2019-04-18T16:41:49Z">
  <state datetime="2018-03-01">REFERRED</state>
  <status>
    <introduced datetime="2018-03-01"/>
  </status>
  <introduced datetime="2018-03-01"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.</title>
    <title type="short" as="introduced">End Taxpayer Subsidies for Drug Ads Act</title>
    <title type="short" as="introduced">End Taxpayer Subsidies for Drug Ads Act</title>
    <title type="display">End Taxpayer Subsidies for Drug Ads Act</title>
  </titles>
  <sponsor bioguide_id="M001170"/>
  <cosponsors>
    <cosponsor bioguide_id="B000944" joined="2018-03-05"/>
    <cosponsor bioguide_id="K000383" joined="2018-07-25"/>
    <cosponsor bioguide_id="S001181" joined="2018-03-01"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-03-01" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="3411"/>
    <bill type="h" session="115" relation="unknown" number="1776"/>
    <bill type="s" session="115" relation="unknown" number="771"/>
  </relatedbills>
  <subjects>
    <term name="Taxation"/>
    <term name="Business expenses"/>
    <term name="Income tax deductions"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-01T05:00:00Z" status="Introduced in Senate">End Taxpayer Subsidies for Drug Ads Act

This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.

"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.</summary>
  <committee-reports/>
</bill>
